Fidelity Investments
IMMX icon

Fidelity Investments’s Immix Biopharma IMMX Stock Holding History

Fidelity Investments’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629 Buy
+61
New +$566 ﹤0.01% 5292
2023
Q1 		– Sell
-7
Closed -$16 – 5405
2022
Q4 		$16 Sell
7
-2
-22% -$3 ﹤0.01% 5167
2022
Q3 		$0 Buy
+9
New +$20 ﹤0.01% 5153

Other funds holding IMMX

JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's IMMX Position: Q2 2026 in Review

Fidelity Investments opened a new position in Immix Biopharma (IMMX) in Q2 2026: 61 shares worth $629. The stake represents ﹤0.01% of the portfolio and ranks #5292 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in IMMX as recently as Q4 2022.

Fidelity Investments first reported a position in IMMX in Q3 2022 and has held it in 3 quarters since. 109 funds tracked by Wall St. Rank hold IMMX as of Q2 2026.

  • Fidelity Investments held 61 shares of Immix Biopharma worth $629 as of Q2 2026.
  • Immix Biopharma was a new Fidelity Investments position in Q2 2026.
  • Immix Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5292 holding.
  • Fidelity Investments first reported a position in Immix Biopharma in Q3 2022 and has held it in 3 quarters since.
  • 109 funds tracked by Wall St. Rank held Immix Biopharma as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.